NASDAQ:COAG | Income Statement | Hemab Therapeutics Holdings, Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$20.34M$5.74M$26.08M-$26.08M-$24.05M$97,000.00-$24.15M-$0.80-$0.8030,111,33830,111,338
2026-03-31$19.46M$4.15M$23.61M-$23.61M-$22.68M$12,000.00-$22.69M-$23.98-$23.98946,000946,000
2025-06-30$12.87M$3.18M$16.06M-$16.06M-$12.21M$4,000.00-$12.21M-$12.91-$12.91946,000946,000
2025-03-31$14.1M$2.46M$16.56M-$16.56M-$15.5M-$190,000.00-$15.31M-$16.18-$16.18946,000946,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares